|
|||||
|
|

Uniform and facility services provider Cintas (NASDAQ:CTAS) reported Q4 CY2025 results exceeding the market’s revenue expectations, with sales up 9.3% year on year to $2.8 billion. The company expects the full year’s revenue to be around $11.19 billion, close to analysts’ estimates. Its GAAP profit of $1.22 per share was 2% above analysts’ consensus estimates.
Is now the time to buy CTAS? Find out in our full research report (it’s free for active Edge members).
Cintas delivered fourth-quarter results that were in line with Wall Street’s expectations, posting steady revenue growth across its core businesses. Management credited strong execution in its route-based businesses, with CEO Todd Schneider highlighting, "Each of our three route-based businesses had strong revenue growth in the quarter." The company’s focus on operational efficiency, supply chain management, and customer retention supported healthy margins despite a competitive environment. Management pointed to productivity improvements and cross-selling efforts as key drivers of the quarter’s performance, while also noting that the company continues to generate growth even when broader employment trends soften.
Looking ahead, Cintas’ updated guidance reflects confidence in sustaining mid- to high single-digit organic growth, supported by high customer retention and ongoing investments in technology. CEO Todd Schneider stated, "We remain committed to leveraging our investments to sustain our positive momentum and deliver exceptional customer service." Management cited further opportunities in cross-selling, product innovation, and vertical market expansion as drivers of its outlook. While acknowledging that tougher comparisons and macroeconomic uncertainty could create headwinds, leadership believes Cintas’ diversified customer base and flexible operating model position it for continued growth.
Management attributed the quarter’s performance to broad-based growth across all segments and continued focus on operational excellence, with notable gains in customer retention and segment profitability.
Management expects continued growth driven by vertical expansion, technology investments, and disciplined pricing, though acknowledges tough comparisons and potential macroeconomic headwinds.
Looking ahead, the StockStory team will be watching (1) the pace of cross-selling and vertical penetration, especially in healthcare and government; (2) the impact of ongoing technology and automation investments on operational efficiency and margin stability; and (3) the company’s ability to sustain all-time high retention rates amidst economic uncertainty. Execution on M&A and integration, as well as tariff and sourcing cost management, will also be important markers of success.
Cintas currently trades at $189.15, in line with $187.37 just before the earnings. In the wake of this quarter, is it a buy or sell? Find out in our full research report (it’s free for active Edge members).
Your portfolio can’t afford to be based on yesterday’s story. The risk in a handful of heavily crowded stocks is rising daily.
The names generating the next wave of massive growth are right here in our Top 6 Stocks for this week. This is a curated list of our High Quality stocks that have generated a market-beating return of 244% over the last five years (as of June 30, 2025).
Stocks that have made our list include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-micro-cap company Tecnoglass (+1,754% five-year return). Find your next big winner with StockStory today.
| 1 hour | |
| 10 hours | |
| Dec-18 | |
| Dec-18 | |
| Dec-18 | |
| Dec-18 | |
| Dec-18 | |
| Dec-18 | |
| Dec-18 | |
| Dec-18 | |
| Dec-18 | |
| Dec-18 | |
| Dec-18 | |
| Dec-17 | |
| Dec-17 |
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite